EMCURE
NSEEmcure Pharmaceuticals Limited (SMALL CAP)
Healthcare>Healthcare>Pharmaceuticals & Biotechnology>Pharmaceuticals
₹1,736.20
52.90 (3.14%)
High VOLATILITY
As on 12 Jun 2026
Price History
Market Cap
The total value of all a company's shares of stock. It's a quick way to gauge a company's size and value.
₹32.91K Cr
SMALL CAP
P/E Ratio
Price-to-Earnings ratio. It shows how much you pay for ₹1 of the company's earnings. A lower P/E might mean it's undervalued, but it varies by industry.
33.9
Industry
The specific business sector the company operates in. Useful for comparing with similar companies.
Pharmaceuticals
52-Week Range
The highest and lowest price at which the stock has traded in the last year (52 weeks). It helps show how volatile the stock is and where it is currently priced relative to its recent history.
52W Low₹1,228.9+41.3%
52W High₹1,830-5.1%
Current Price
₹1,736.20
Circuit Limits (10%)
The maximum allowed price movement (up or down) in a single trading day to prevent excessive volatility. If the stock hits these limits, trading may be temporarily halted.
Lower Circuit₹1,562.58
Upper Circuit₹1,909.82
Reference Price
₹1,736.20
Investment Checklist
Triple Bottom on 1D (BREAKOUT CONFIRMED) — target ₹1591.0
Triple Bottom on 1D (BREAKOUT CONFIRMED) — target ₹1576.7
Trend: Price above all key MAs — strong uptrend | Bullish MA stack (20>50>200)
Composite score 44.31 (BUY) with 88.3% confidence
EMA(9) Crossover: Price crossed above EMA(9): Fresh bullish momentum signal.
Technical Analysis
Technical Analysis
Analysis from 2026-06-12
Confidence
88%
Trend
BULLISH
BULLISH
Price above all key MAs — strong uptrend | Bullish MA stack (20>50>200)
EMA20
1712.61
EMA50
1670.51
EMA200
1524.58
Price Action
MIXED
NEUTRAL
Higher Highs5
Higher Lows3
Lower Highs4
Lower Lows6
Support & Resistance Levels
Resistance (Above)
₹1757.90
₹1830.00
Support (Below)
₹1677.32
₹1585.60
₹1565.20
₹1543.00
₹1519.90
Volume Analysis
TrendINCREASING
Change+36.20%
Unusual VolumeNo
Stop Loss Levels
Fixed Risk
1% Risk₹1718.84
3% Risk₹1684.11
5% Risk₹1649.39
7% Risk (Custom)
₹1614.67Technical Levels
1x ATR (Volatility)₹1672.30
2x ATR (Swing)₹1608.40
3x ATR (Trend)₹1544.50
Immediate Support₹1677.32
Moving Averages
EMA 9 (Short-term)₹1722.20
EMA 20 (Medium-term)₹1712.61
EMA 50 (Trend)₹1670.51
EMA 200 (Long-term)₹1524.58
Financials
Financial Analysis
| Metric | Mar '25 | Jun '25 | Sep '25 | Dec '25 |
|---|---|---|---|---|
| Revenue | ₹2,028.5 Cr | ₹2,100.5 Cr | ₹2,269.8 Cr | ₹2,363.5 Cr |
| Net Profit | ₹189 Cr | ₹207 Cr | ₹243.5 Cr | ₹230.5 Cr |
| EPS | — | ₹10.92 | ₹12.85 | ₹12.16 |
| Operating Profit | ₹360.7 Cr | ₹417 Cr | ₹478.6 Cr | ₹456.4 Cr |
ROE
15.32%
ROCE
20.32%
Debt/Equity
0.23
Current Ratio
1.71
OPM
19.31%
NPM
9.75%
Peer Comparison
PharmaceuticalsPeer Comparison
| Symbol | Name | Price | Change |
|---|---|---|---|
| SUNPHARMA | Sun Pharmaceutical Industries Limited | ₹1,807.70 | +0.75% |
| DIVISLAB | Divi's Laboratories Limited | ₹6,638.00 | -0.26% |
| TORNTPHARM | Torrent Pharmaceuticals Limited | ₹4,571.20 | -0.02% |
| CIPLA | Cipla Limited | ₹1,389.40 | +0.44% |
| ZYDUSLIFE | Zydus Lifesciences Limited | ₹1,104.70 | -0.11% |
| DRREDDY | Dr. Reddy's Laboratories Limited | ₹1,275.40 | -0.05% |
| LUPIN | Lupin Limited | ₹2,293.30 | +0.88% |
| MANKIND | Mankind Pharma Limited | ₹2,381.10 | +0.35% |
| AUROPHARMA | Aurobindo Pharma Limited | ₹1,472.80 | +0.59% |
| LAURUSLABS | Laurus Labs Limited | ₹1,394.30 | +0.25% |
Corporate Information
Large Deals
View AllBulk, Block and Short deals reported for this stock.
Loading Deals...
Corporate Actions
Recent actions
| Ex Date | Purpose | Type |
|---|---|---|
| 14 Aug 2025 | Dividend - Rs 3 Per Share | DIVIDEND |
Announcements
Latest updates
Board Meetings
Upcoming and past meetings
Corporate Events
Upcoming results & meetings
No upcoming events found
We couldn't find any scheduled corporate actions for this symbol at the moment.
Latest News
News for EMCURE
View All
neutral
ET Markets - Stocks 3d ago
Stocks in news: Emcure Pharma, Dixon Technologies, Ajanta Pharma, Godrej Properties, Vedanta
Indian markets experienced a volatile session, closing higher amidst mixed signals. Bulls are defending the 23,000 level in Nifty, but uncertainty persists due to mixed heavyweight stock trends. Investors are advised to focus on stock-specific opportunities as analysts maintain a cautious outlook.
AJANTPHARMDIVOPPBEESDIXONEMCUREFOCUSGODREJINDGODREJPROPGROWWCAPMPHARMABEESVEDLConsumer DurablesDiversified
positive
ET Markets - Stocks 3d ago
PE investor BC Investments sells Rs 612 crore stake in Emcure Pharma; Kotak MF picks up stake
Private equity firm BC Investments IV sold a Rs 612 crore stake in Emcure Pharmaceuticals to Kotak Mahindra Mutual Fund at Rs 1,700 per share. Despite this divestment, analysts remain positive on Emcure's growth outlook across its core therapeutic segments.
ABSLPSEALPHAALPHAETFAONEGOLDAONELIQUIDAONENIFTYAONESILVERAONETOTALAUTOBEESAUTOIETFAXISBNKETFAXISBPSETFAXISCETFAXISGOLDAXISHCETFAXISILVERAXISNIFTYAXISTECETFAXISVALUEAXSENSEXBANK10ADDBANKADDBANKBETFBANKETFBANKPSUBBETF0432BBNPNBETFBBNPPGOLDBFSICHEMICALCHOICEGOLDCOMMOIETFDEFENCEDIVIDENDEBANKNIFTYEBBETF0430EBBETF0431EBBETF0433ECAPINSUREEGOLDELIQUIDELM250EMCUREENERGYENIFTYEQUAL200EQUAL50EQUAL50ADDESENSEXESGESILVERFINIETFFLEXIADDFMCGADDFMCGIETFGILT10BETAGILT5BETAGOLD1GOLD360GOLDADDGOLDBETAGOLDBNDGOLDETFGROWWCAPMGROWWCHEMGROWWDEFNCGROWWEVGROWWGOLDGROWWHOSPIGROWWLIQIDGROWWLOVOLGROWWMC150GROWWMETALGROWWMOM50GROWWN200GROWWNETGROWWNIFTYGROWWNXT50GROWWPOWERGROWWPSEGROWWPSUBKGROWWRAILGROWWRLTYGROWWSC250GROWWSLVRGSEC10IETFGSEC10YEARHDFCGOLDHDFCGROWTHHDFCLOWVOLHDFCMID150HDFCMOMENTHDFCNEXT50HDFCNIF100HDFCNIFITHDFCPSUBKHDFCPVTBANHDFCQUALHDFCSILVERHDFCSML250HDFCVALUEHEALTHADDHEALTHCAREHEALTHIETFHSBCGOLDICICIB22INFRAIETFINTERNETITADDITBEESITBETAITETFITIETFKOTAKBANKLICNETFSENLICNMID100LIQGRWBEESLIQUIDLIQUID1LIQUIDPLUSLIQUIDSBILIQUIDSHRILOWVOLMAFANGMAHKTECHMAKEINDIAMANUFGBEESMASPTOP50METALMETALIETFMID150MIDCAPADDMIDCAPBETAMIDCAPETFMIDCAPIETFMIDQ50ADDM&MMNCMOALPHA50MOBANK10MOCAPITALMODEFENCEMOENERGYMOGOLDMOGSECMOHEALTHMOINFRAMOIPOMOLOWVOLMOM100MOM30IETFMOM50MOMENTUMMOMENTUM30MOMENTUM50MOMGFMOMIDMTMMOMNCMOMOMENTUMMON100MON50EQUALMONEXT50MONIFTY100MONIFTY500MONQ50MOPSEMOQUALITYMOREALTYMOSERVICEMOSILVERMOSMALL250MOTOURMOVALUEMSCIADDMSCIINDIAMULTICAPNEXT30ADDNEXT50NEXT50ADDNEXT50BETANEXT50ETFNEXT50IETFNIFTY100EWNIFTYADDNIFTYBETFNIFTYETFNIFTYQLITYOILIETFPHARMABEESPSUBANKADDPSUBNKIETFPVTBANKADDQUALITY30SBIBPBSBIETFCONSBIETFITSBIETFPBSBIETFQLTYSBILIQETFSBINEQWETFSBINMID150SBISILVERSELECTIPOSENSEXETFSETF10GILTSILVERSILVER1SILVER360SILVERADDSILVERAGSILVERBEESSILVERBETASILVERBNDSILVERIETFSMALL250SMALLADDSNXT30BEESTATAGOLDTATSILVTECHTNIDETFTOP10ADDTOP20TWCGOLDETFUNIONGOLDVAL30IETFVALUEAutomobile and Auto ComponentsFinancial Services
positive
CNBC TV18 - Markets 4d ago
Block deals: Four stocks see large trades worth over ₹2,000 crore on Tuesday; Check how they reacted
Barring Bluestone Jewellery, whose shares are trading with losses of over 5%, shares of Ajanta Pharma, Emcure Pharma, and Capital Small Finance Bank are trading with gains between 1% to 4% after their respective block deals on Tuesday.
AJANTPHARMAKCAPITAUBANKBANKINDIABLUESTONECAPITALSFBCIFLCPCAPEMCUREEQUITASBNKESAFSFBINDOSTARJSFBLTFSURYODAYUJJIVANSFBUTKARSHBNKConsumer DurablesFinancial Services